Doximity, Inc. $DOCS Position Lowered by Northern Trust Corp

Key Points

• Northern Trust Corp reduced its stake in Doximity, Inc. by 0.3%, now owning approximately 1.45 million shares valued at $84.43 million.
• Doximity's recent quarterly earnings report showed an EPS of $0.36, surpassing estimates and reflecting a 15.2% increase in revenue compared to the previous year.
• Institutional investors now hold 87.19% of Doximity's stock, indicating a strong interest from larger market players.

Northern Trust Corp decreased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 0.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,454,998 shares of the company's stock after selling 4,187 shares during the period. Northern Trust Corp owned about 0.78% of Doximity worth $84,434,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of DOCS. Guggenheim Capital LLC bought a new position in shares of Doximity during the fourth quarter worth about $359,000. Dimensional Fund Advisors LP raised its stake in Doximity by 4.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after acquiring an additional 63,815 shares during the period. Tower Research Capital LLC TRC raised its stake in Doximity by 348.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,972 shares of the company's stock worth $426,000 after acquiring an additional 6,195 shares during the period. Stifel Financial Corp raised its stake in Doximity by 4.5% during the fourth quarter. Stifel Financial Corp now owns 51,902 shares of the company's stock worth $2,771,000 after acquiring an additional 2,228 shares during the period. Finally, Hsbc Holdings PLC acquired a new stake in Doximity during the fourth quarter worth about $891,000. Institutional investors own 87.19% of the company's stock.

Doximity Trading Up 5.6%

Shares of NASDAQ:DOCS opened at $67.6930 on Monday. The firm's 50 day moving average is $60.80 and its two-hundred day moving average is $60.49. Doximity, Inc. has a 52 week low of $35.32 and a 52 week high of $85.21. The firm has a market capitalization of $12.68 billion, a P/E ratio of 67.69, a PEG ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period last year, the company earned $0.28 EPS. The firm's revenue for the quarter was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on DOCS. The Goldman Sachs Group set a $50.00 price objective on shares of Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. William Blair reiterated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Canaccord Genuity Group increased their price objective on shares of Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. Mizuho dropped their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday, May 16th. Finally, Needham & Company LLC increased their price objective on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $66.21.

Insider Activity

In other news, Director Regina M. Benjamin sold 10,000 shares of the stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director directly owned 16,618 shares in the company, valued at $997,080. This trade represents a 37.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 36,000 shares of company stock worth $2,140,940 over the last three months. Corporate insiders own 31.30% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.